Somatic mutations of (a) AKT1 E17K have been associated with Proteus syndrome and a number of cancers [26, 43]; (b) AKT2 with lipodystrophy and hypoglycaemia [27]; and AKT3 with neuronal migration defects and hemimegalencephaly [28]. Here, AKT1 is linked to cancer.